Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases
Clinical trial NCT07178938 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07178938
- Sponsor
- MedSIR
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2026-11-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.